Company Encyclopedia
View More
name
Cardlytics
CDLX.US
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. Cardlytics, Inc.
399.32 B
CDLX.USMarket value -Rank by Market Cap -/-

Financial Score

13/12/2025 Update
D
MediaIndustry
Industry Ranking90/117
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-341.04%E
    • Profit Margin-44.12%E
    • Gross Margin46.70%B
  • Growth ScoreD
    • Revenue YoY-14.41%E
    • Net Profit YoY59.63%B
    • Total Assets YoY-26.69%E
    • Net Assets YoY-106.75%E
  • Cash ScoreD
    • Cash Flow Margin-226.64%D
    • OCF YoY-14.41%E
  • Operating ScoreB
    • Turnover0.73B
  • Debt ScoreE
    • Gearing Ratio101.61%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Cardlytics CFO Alexis DeSieno Resigns Effective March 2026

    Cardlytics Inc. announced the resignation of CFO Alexis DeSieno, effective by March 6, 2026, or upon the appointment of her successor. The company is searching for a new CFO, and DeSieno may stay in an advisory role during the transition. This announcement was made via EDGAR by Cardlytics Inc. on December 5, 2025.

    Reuters·
    US
    CDLX
    -7.69%
    Reuters·
    US
    CDLX
    -7.69%

    Cardlytics Faces Challenges Amid Transition from Key Partner Chase, Leading to Sell Rating

    Cardlytics faces significant challenges as it transitions away from its key partner, Chase, leading to a Sell rating from Bank of America analyst Omar Dessouky, who set a price target of $1.50. Despite third-quarter results meeting expectations, the ongoing transition is expected to hinder revenue stabilization and growth. Management's efforts to diversify partnerships and introduce new products are overshadowed by uncertainty regarding Chase's loss, compounded by cautious fourth-quarter guidance. The lack of visible growth and a viable profit model makes Cardlytics a difficult investment in the AdTech sector.

    Tip Ranks·
    US
    CDLX
    -7.69%
    Tip Ranks·
    US
    CDLX
    -7.69%

    Cardlytics shares are trading lower after the company reported worse-than-expected Q3 sales results.

    benzinga_article·
    US
    CDLX
    -7.69%
    benzinga_article·
    US
    CDLX
    -7.69%

    Arteris Inc reports results for the quarter ended September 30 - Earnings Summary

    Arteris Inc reported a quarterly adjusted loss of 9 cents per share for the quarter ended September 30, compared to a loss of 8 cents in the same quarter last year. Revenue increased by 18.3% to $17.41 million, exceeding analyst expectations of $17.00 million. The company reported a total loss of $8.99 million. Analysts maintain a "buy" rating on the stock, with a median 12-month price target of $16.75, representing a 26.4% upside from the last closing price of $12.32.

    Reuters·
    US
    AIP
    -17.18%
    Reuters·
    US
    AIP
    -17.18%

    Cardlytics | 10-Q: FY2025 Q3 Revenue Misses Estimate at USD 52.03 M

    LB filings·
    US
    CDLX
    -7.69%
    LB filings·
    US
    CDLX
    -7.69%
    © 2025 Longbridge｜Disclaimer